Home » Topics » BioWorld Science

BioWorld Science
RSS

IKZF2 degrader PLX-4107 shows promise as cancer immunotherapeutic

April 19, 2022

Insilico Medicine nominates USP1 small-molecule inhibitor as preclinical candidate

April 14, 2022

Inhaled CYB-004 shows advantages over intravenous and inhaled DMT

April 14, 2022

Artelo reports new preclinical data for GPCR agonist ART-27.13 for cancer-induced cachexia

April 14, 2022

SPK-001 demonstrates neutralization activity in vitro against SARS-CoV-2 variants of concern

April 14, 2022

VantAI and Janssen establish protein degrader discovery collaboration

April 14, 2022

AACR 2022: With ADCs established, branching out to irregular conjugation

April 14, 2022

BAY-3375968: a new anti-CCR8 antibody for cancer immunotherapy

April 14, 2022

HDAC6 inhibition prevents peripheral nerve injury-induced hypersensitivity

April 14, 2022

NXP-800, orally available HSF1 pathway inhibitor with antitumor activity

April 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...